Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.
about
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts.A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative reviewCellular senescence, senescence-associated secretory phenotype, and chronic kidney diseaseHigh Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes.
P2860
Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@en
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@nl
type
label
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@en
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@nl
prefLabel
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@en
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@nl
P2093
P2860
P356
P1476
Fibroblast growth factor 23 mo ...... n experimental renal fibrosis.
@en
P2093
Gerjan Navis
Jacob van den Born
Jan-Luuk Hillebrands
Joost G Hoenderop
Katarina Mirkovic
Maarten A de Jong
Marc G Vervloet
Martin H de Borst
NIGRAM consortium
René J Bindels
P2860
P356
10.1093/NDT/GFW105
P407
P577
2017-01-01T00:00:00Z